Fungitraxx

Country: European Union

Language: Maltese

Source: EMA (European Medicines Agency)

Active ingredient:

Itraconazole

Available from:

Avimedical B.V.

ATC code:

QJ02AC02

INN (International Name):

itraconazole

Therapeutic group:

Avjan

Therapeutic area:

Antimikotiċi għall-użu sistemiku-derivati Triazole, itraconazole

Therapeutic indications:

Għat-trattament ta ' asperġillożi u kandidjasi fil-ħbieb l-għasafar,.

Product summary:

Revision: 2

Authorization status:

Awtorizzat

Authorization date:

2014-03-12

Patient Information leaflet

                                15
B. FULJETT TA’ TAGĦRIF
16
FULJETT TA’ TAGĦRIF GĦAL:
FUNGITRAXX 10 MG/ML SOLUZZJONI ORALI GĦAL GĦASAFAR ORNAMENTALI
1.
L-ISEM U L-INDIRIZZ TAD-DETENTUR TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID
FIS-SUQ U TAD-DETENTUR TAL-AWTORIZZAZZJONI GĦALL-MANIFATTURA
RESPONSABBLI MILL-ĦRUĠ TAL-LOTT, JEKK DIFFERENTI
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
Avimedical B.V.
Abbinkdijk 1
7255 LX Hengelo (Gld)
IL-PAJJIŻI L-BAXXI
Manifattur responsabbli mill-ħruġ tal-lott:
Floris Veterinaire Produkten B.V.
Kempenlandstraat 33
5262 GK Vught
IL-PAJJIŻI L-BAXXI
2.
ISEM TAL-PRODOTT MEDIĊINALI VETERINARJU
Fungitraxx 10 mg/ml soluzzjoni orali għal għasafar ornamentali
itraconazole
3.
DIKJARAZZJONI TAS-SUSTANZA ATTIVA U INGREDJENT(I) OĦRA
SUSTANZA ATTIVA:
Itraconazole
10 mg/ml
DESKRIZZJONI:
Soluzzjoni ċara, safra għal ftit ambra.
4.
INDIKAZZJONI(JIET)
Psittaciformi, Falkoniformi, Aċċipitriformi, Strigiformi, u
Anseriformi:
Għall-kura ta’ asperġillożi.
Psittaciformi (biss):
Anke għall-kura ta’ kandidjasi.
5.
KONTRAINDIKAZZJONIJIET
Tużax fuq għasafar maħsuba għall-konsum mill-bniedem.
Tużax f’każijiet ta’ ipersensittività għas-sustanza attiva jew
għal kwalunkwe wieħed mill-eċċipjenti.
17
6.
REAZZJONIJIET AVVERSI
Ġeneralment itraconazole għandu marġini dejjaq ta’ sigurtà
fl-għasafar.
Rimettar, telf ta’ aptit u telf ta’ piż kienu komunement
osservati f’għasafar ittrattati, madankollu, dawn ir-
reazzjonijiet avversi huma ġeneralment ħfief u relatati mad-doża.
Jekk ikun hemm rimettar, telf ta’ aptit jew
telf ta’ piż, allura mal-ewwel okkorrenza huwa rakkomandabbli li
d-doża titbaxxa (ara sezzjoni “Twissijiet
speċjali”) jew il-kura bil-mediċina veterinarja għandha
titwaqqaf.
Il-frekwenza tar-reazzjonijiet avversi hija definita skont din
il-konvenzjoni:
- komuni ħafna (aktar minn wieħed f’10 annimali trattat li juru
reazzjoni(jiet) avversa(i))
- komuni (aktar minn wieħed iżda inqas minn 10 annimali f’100
annimal trattat)
- mhux komuni (aktar minn wieħed
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                1
_ _
ANNESS I
SOMMARJU TAL-KARATTERISTIĊI TAL-PRODOTT
2
1.
ISEM TAL-PRODOTT MEDIĊINALI VETERINARJU
Fungitraxx 10 mg/ml soluzzjoni orali għal għasafar ornamentali
2.
KOMPOŻIZZJONI KWALITATTIVA U KWANTITATTIVA
Kull ml fih:
SUSTANZA ATTIVA:
Itraconazole
10 mg.
Għal-lista sħiħa tal-eċċipjenti, ara s-sezzjoni 6.1.
3.
GĦAMLA FARMAĊEWTIKA
Soluzzjoni orali.
Soluzzjoni ċara, safra għal ftit ambra.
4.
TAGĦRIF KLINIKU
4.1
SPEĊI FIL-MIRA
Għasafar ornamentali, partikolarment:
Psittaciformi (speċifikament kakatuwi u pappagalli veri: parrukketti;
amorini)
Falkoniformi (falkuni)
Aċċipitriformi (isqra)
Strigiformi (kokki)
Anseriformi (speċifikament ċinji)
4.2
INDIKAZZJONIJIET GĦAL UŻU, LI JISPEĊIFIKAW L-ISPEĊI FIL-MIRA
Psittaciformi, Falkoniformi, Aċċipitriformi, Strigiformi, u
Anseriformi:
Għall-kura ta’ asperġillożi.
Psittaciformi (biss):
Anke għall-kura ta’ kandidjasi.
4.3
KONTRA INDIKAZZJONIJIET
Tużax fuq għasafar maħsuba għall-konsum mill-bniedem.
Tużax f’każijiet ta’ ipersensittività għas-sustanza attiva jew
għal kwalunkwe wieħed mill-eċċipjenti.
4.4
TWISSIJIET SPEĊJALI GĦAL KULL SPEĊI FIL-MIRA
Xejn.
3
4.5
PREKAWZJONIJIET SPEĊJALI GĦALL-UŻU
Prekawzjonijiet speċjali għall-użu fl-annimali
Ġeneralment itraconazole mhuwiex ittollerat tajjeb mill-Pappagalli
Griżi Afrikani u għalhekk il-
prodott għandu jintuża biss b’kawtela f’din l-ispeċi u jekk ma
jkun hemm l-ebda kura alternattiva
disponibbli u bl-aktar doża baxxa rakkomandata għat-tul kollu
tal-perjodu ta’ kura rakkomandat.
Psittaciformi oħra jidhru wkoll li huma anqas tolleranti għal
itraconazole minn għasafar oħra.
Għalhekk, jekk ikun hemm reazzjoni avversi suspettati bħal emesi,
anoreksja jew telf ta’ piż, id-doża
għandha titnaqqas jew il-kura bil-prodott mediċinali għandha
titwaqqaf.
Fejn ikun hemm aktar minn għasfur wieħed fid-dar/gaġġa,
l-għasafar kollha infettati u trattati
għandhom jiġu separati minn għasafar oħra.
Skont it-trobbija tajba tal-annimali, għandu jiġu rakko
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 27-03-2019
Summary of Product characteristics Summary of Product characteristics Bulgarian 27-03-2019
Public Assessment Report Public Assessment Report Bulgarian 29-04-2014
Patient Information leaflet Patient Information leaflet Spanish 27-03-2019
Public Assessment Report Public Assessment Report Spanish 29-04-2014
Patient Information leaflet Patient Information leaflet Czech 27-03-2019
Public Assessment Report Public Assessment Report Czech 29-04-2014
Patient Information leaflet Patient Information leaflet Danish 27-03-2019
Public Assessment Report Public Assessment Report Danish 29-04-2014
Patient Information leaflet Patient Information leaflet German 27-03-2019
Public Assessment Report Public Assessment Report German 29-04-2014
Patient Information leaflet Patient Information leaflet Estonian 27-03-2019
Public Assessment Report Public Assessment Report Estonian 29-04-2014
Patient Information leaflet Patient Information leaflet Greek 27-03-2019
Public Assessment Report Public Assessment Report Greek 29-04-2014
Patient Information leaflet Patient Information leaflet English 27-03-2019
Public Assessment Report Public Assessment Report English 29-04-2014
Patient Information leaflet Patient Information leaflet French 27-03-2019
Public Assessment Report Public Assessment Report French 29-04-2014
Patient Information leaflet Patient Information leaflet Italian 27-03-2019
Public Assessment Report Public Assessment Report Italian 29-04-2014
Patient Information leaflet Patient Information leaflet Latvian 27-03-2019
Public Assessment Report Public Assessment Report Latvian 29-04-2014
Patient Information leaflet Patient Information leaflet Lithuanian 27-03-2019
Summary of Product characteristics Summary of Product characteristics Lithuanian 27-03-2019
Public Assessment Report Public Assessment Report Lithuanian 29-04-2014
Patient Information leaflet Patient Information leaflet Hungarian 27-03-2019
Summary of Product characteristics Summary of Product characteristics Hungarian 27-03-2019
Public Assessment Report Public Assessment Report Hungarian 29-04-2014
Patient Information leaflet Patient Information leaflet Dutch 27-03-2019
Public Assessment Report Public Assessment Report Dutch 29-04-2014
Patient Information leaflet Patient Information leaflet Polish 27-03-2019
Public Assessment Report Public Assessment Report Polish 29-04-2014
Patient Information leaflet Patient Information leaflet Portuguese 27-03-2019
Summary of Product characteristics Summary of Product characteristics Portuguese 27-03-2019
Public Assessment Report Public Assessment Report Portuguese 29-04-2014
Patient Information leaflet Patient Information leaflet Romanian 27-03-2019
Public Assessment Report Public Assessment Report Romanian 29-04-2014
Patient Information leaflet Patient Information leaflet Slovak 27-03-2019
Public Assessment Report Public Assessment Report Slovak 29-04-2014
Patient Information leaflet Patient Information leaflet Slovenian 27-03-2019
Summary of Product characteristics Summary of Product characteristics Slovenian 27-03-2019
Public Assessment Report Public Assessment Report Slovenian 29-04-2014
Patient Information leaflet Patient Information leaflet Finnish 27-03-2019
Public Assessment Report Public Assessment Report Finnish 29-04-2014
Patient Information leaflet Patient Information leaflet Swedish 27-03-2019
Public Assessment Report Public Assessment Report Swedish 29-04-2014
Patient Information leaflet Patient Information leaflet Norwegian 27-03-2019
Summary of Product characteristics Summary of Product characteristics Norwegian 27-03-2019
Patient Information leaflet Patient Information leaflet Icelandic 27-03-2019
Summary of Product characteristics Summary of Product characteristics Icelandic 27-03-2019
Patient Information leaflet Patient Information leaflet Croatian 27-03-2019
Public Assessment Report Public Assessment Report Croatian 29-04-2014

Search alerts related to this product

View documents history